ADC TOXICITY ATLAS
Payloads & linkers
Payload · Auristatin

Auristatin W

Tubulin inhibitor

CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N4CCCCO4)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC
Physicochemistry

Properties

MW
746 Da
XLogP3
2.6
logD₇.₄
1.5
TPSA
158 Ų
pKa
3.5
Charge pH 7.4
Zwitterion
H-bond donors
4
H-bond acceptors
9
Bystander
No
PubChem CID
86678408
Bioactivity
Auristatin W is a microtubule-inhibiting auristatin (dolastatin-10 analog); ADCdb lists payload mechanism as 'Microtubule (MT)' disruption. No discrete payload IC50 reported on ADCdb/PubChem. Clinically (first-in-human phase I, PMID 31502117) the ADC was terminated for poor toler
1 agent

ADCs built on this payload

Agent · target
Ocular
Hepatic
Neutrop.
Thrombo.
Anemia
GI
ILD
Neuro.
Aprutumab ixadotinFGFR2
40
60
50
30
25
0%severity100%
0
Assessed · clear
true 0%
No data
never assessed